image
Healthcare - Biotechnology - NASDAQ - US
$ 2.7376
-1.82 %
$ 7.42 M
Market Cap
-2.23
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
4416.55%
EBIT Estimate
--1393.90%
Net Income Estimate
--1563.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Cyclerion Therapeutics, Inc.
image
CYCN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart CYCN

image
$100.0m$100.0m$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.02019201920202020202120212022202220232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart CYCN

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)2019201920202020202120212022202220232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart CYCN

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)2019201920202020202120212022202220232023202420242025202520262026